Metabolic syndrome among Chinese obese patients with epilepsy on sodium valproate

Seizure

Volumn 21, Issue 8, 2012, Pages 578-582

  Fang, Jiajia ^a   Chen, Sihan ^a   Tong, Nanwei ^a   Chen, Lan ^a   An, Dongmei ^a   Mu, Jie ^a   Zhou, Dong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Epilepsy; Insulin resistance; Metabolic syndrome; Obesity; Relative factors; Valproate related

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VALPROIC ACID;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE DURATION; DRUG BLOOD LEVEL; EPILEPSY; EPILEPTIC STATE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MONOTHERAPY; OBESITY; PRIORITY JOURNAL; TONIC CLONIC SEIZURE; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; ANTICONVULSANTS; ASIAN CONTINENTAL ANCESTRY GROUP; EPILEPSY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; OBESITY; VALPROIC ACID; YOUNG ADULT;

EID: 84865235668     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2012.06.001     Document Type: Article

References (28)

1. R. Davis, D.H. Peters, and D. McTavish Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy Drugs 47 1994 332 372
2. F. Masuccio, A. Verrotti, V. Chiavaroli, T. de Giorgis, C. Giannini, and F. Chiarelli Weight gain and insulin resistance in children treated with valproate: the influence of time Journal of Child Neurology 25 2010 941 947
3. V. Pylvänen, A. Pakarinen, M. Knip, and J. Isojärvi Characterization of insulin secretion in valproate-treated patients with epilepsy Epilepsia 47 2006 1460 1464
4. M.F. Reynolds, E.C. Sisk, and N.L. Rasgon Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review Current Medicinal Chemistry 14 2007 2799 2812
5. F. El-Khatib, M. Rauchenzauner, M. Lechleitner, F. Hoppichler, A. Naser, and M. Waldmann Valproate, weight gain and carbohydrate craving: a gender study Seizure 16 2007 226 232
6. C. Sharpe, T. Wolfson, and D.A. Trauner Weight gain in children treated with valproate Journal of Child Neurology 24 2009 338 341
7. M. Strassnig, J. Miewald, M. Keshavan, and R. Ganguli Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis Schizophrenia Research 93 2007 90 98
8. H.H. Chang, Y.K. Yang, P.W. Gean, H.C. Huang, P.S. Chen, and R.B. Lu The role of valproate in metabolic disturbances in bipolar disorder patients Journal of Affective Disorders 124 2010 319 323
9. V. Pylvanen, A. Pakarinen, M. Knip, and J. Isojarvi Insulin-related metabolic changes during treatment with valproate in patients with epilepsy Epilepsy & Behavior 8 2006 643 648
10. A. Verrotti, R. la Torre, D. Trotta, A. Mohn, and F. Chiarelli Valproate-induced insulin resistance and obesity in children Hormone Research 71 2009 125 131
11. J.Y. Kim, and H.W. Lee Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy Epilepsia 48 2007 1366 1370
12. D. Haupt Differential metabolic effects of antipsychotic treatments European Neuropsychopharmacology 16 2006 S149 S155
13. V. Pylvanen, M. Knip, A.J. Pakarinen, J. Turkka, M. Kotila, and J. Rattya Fasting serum insulin and lipid levels in men with epilepsy Neurology 60 2003 571 574
14. B. Wang, Y. Liu, P. He, B. Dong, L. OuYang, and Y. Ma Prevalence of metabolic syndrome in an elderly Chinese population: a community-based cross-sectional study Journal of the American Geriatrics Society 58 2010 2027 2028
15. S.M. Grundy Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 112 2005 2735 2752
16. J.F. Fu, L. Liang, C.C. Zou, F. Hong, C.L. Wang, and X.M. Wang Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention International Journal of Obesity (London) 31 2007 15 22
17. K.M. de Almeida, C.L.R.L. Moreira, and B. Lafer Metabolic syndrome and bipolar disorder: what should psychiatrists know? CNS Neuroscience & Therapeutics 18 2012 160 166
18. J.L. Elmslie, R.J. Porter, P.R. Joyce, P.J. Hunt, B.I. Shand, and R.S. Scott Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls Australian and New Zealand Journal of Psychiatry 43 2009 53 60
19. A. Verrotti, R. Manco, S. Agostinelli, G. Coppola, and F. Chiarelli The metabolic syndrome in overweight epileptic patients treated with valproic acid Epilepsia 51 2010 268 273
20. J. Engel Jr. ILAE classification of epilepsy syndromes Epilepsy Research 70 Suppl. 1 2006 S5 S10
21. E. Anuurad, K. Shiwaku, A. Nogi, K. Kitajima, B. Enkhmaa, and K. Shimono The new BMI criteria for Asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers Journal of Occupational Health 45 2003 335 343
22. A. Katsuki, Y. Sumida, E.C. Gabazza, S. Murashima, M. Furuta, and R. Araki-Sasaki Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with Type 2 diabetes Diabetes Care 24 2001 362 365
23. A. Abaci, M. Saygi, U. Yis, K. Demir, E. Dirik, and E. Bober Metabolic alterations during valproic acid treatment: a prospective study Pediatric Neurology 41 2009 435 439
24. J.I. Isojarvi, J. Rattya, V.V. Myllyla, M. Knip, R. Koivunen, and A.J. Pakarinen Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy Annals of Neurology 43 1998 446 451
25. J. Zeitlhofer, A. Doppelbauer, G. Tribl, T. Leitha, and L. Deecke Changes of serum lipid patterns during long-term anticonvulsive treatment Journal of Molecular Medicine 71 1993 574 578
26. A. Verrotti, R. Greco, G. Latini, M. De Simone, and F. Chiarelli Obesity and plasma concentrations of alpha-tocopherol and beta-carotene in epileptic girls treated with valproate Neuroendocrinology 79 2004 157 162
27. E.J. Gallagher, D. LeRoith, and E. Karnieli Insulin resistance in obesity as the underlying cause for the metabolic syndrome Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 77 2010 511 523
28. A.P. Ferreira, C.E. Oliveira, and N.M. Franca Metabolic syndrome and risk factors for cardiovascular disease in obese children: the relationship with insulin resistance (HOMA-IR) Jornal de Pediatria 83 2007 21 26